Amsterdam, 21 July 2022 – Our portfolio company Mauritskliniek intends to join Corius. Mauritskliniek provides healthcare services in dermatology, varicose veins, proctology, skin therapy and medical-cosmetic care. The Mauritskliniek is located in Amsterdam, The Hague, Nijmegen, Utrecht and Veldhoven. Corius is the largest network of dermatology and phlebology practices in Germany and Switzerland.
By acquiring Mauritskliniek, Corius geographically expands its European healthcare offerings to the Netherlands. Both the services and vision of Mauritskliniek are perfectly consistent with those of Corius.
Mauritskliniek intends to join Corius in the third quarter of 2022, after potential approval of the Nederlandse Zorgautoriteit (NZa).
About Corius
Corius is a network of dermatology and phlebology practices. Doctors and partners of Corius deliver the highest level of quality and apply the most modern technology. An absolute passion for the job and patients is pivotal in the way of working. Corius offers their patients holistic and individual treatments, whereby in-house expert knowledge is shared across cross-clinics and colleagues. Employees follow additional education and trainings throughout. Corius has 32 practices and employs 139 doctors and 615 employees. About 450.000 patients are treated each year. www.corius.de
About Mauritskliniek
Mauritskliniek is a specialized clinic for dermatology, treatment for varicose veins and medical-cosmetic care. After the acquisition of Kliniek Veldhoven in 2020, the range of cosmetic-care has been further expanded. The clinics are known for high quality and a pleasant way of working. Their values are personal, clear and well organized. The clinics offer both insured and uninsured care. Customer satisfaction is rated with 8.6/10 points, according zorgkaartnederland.nl. www.maurtiskliniek.nl
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.
AMP Group acquires Omega Logistics business operations
AMP Group acquires Omega Logistics business operations Houten, 23 May 2022 - Our portfolio company AMP is taking its second step in the buy-and-build strategy with the acquisition of the business activities of Omega Logistics, a medical logistics provider. Through...
Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems
Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems Amsterdam, 21 March 2022 – We’re proud to announce that our portfolio company, CytoSMART Technologies, an innovator in kinetic live-cell imaging analysis, has been acquired by...
YOEP Onderwijs & Zorg joins forces with Ad Astra
YOEP Onderwijs & Zorg joins forces with Ad Astra Amsterdam, 14th of March 2022, Our portfolio company YOEP Onderwijs en Zorg is joining forces with Ad Astra Begeleiding & Behandeling, a youth care provider which focuses on the guidance and treatment of...
Axual raises growth financing from investor Holland Capital
Axual raises growth financing from investor Holland Capital Utrecht/Amsterdam, 10 March 2022 - Holland Capital is investing with a private co-investor in software company Axual, which provides customers with a platform that makes real-time data streaming easier and...
Holland Capital acquires Appronto; extensive collaboration with Magnus Digital, Dimensys, and cards PLM solutions.
Holland Capital acquires Appronto; extensive collaboration with Magnus Digital, Dimensys, and cards PLM solutions 3 February 2022, Holland Capital acquires Appronto, a low-code and integration solutions service provider. The company will closely collaborate with three...
New investment for Prolira for roll-out smart-AI brain state monitor for the hospital market
New investment for Prolira for roll-out smart-AI brain state monitor for the hospital market Utrecht, 1 February 2022 – Holland Capital invests, together with Borski fund, ROM Utrecht Region, Health Innovations and Oost NL, in Prolira BV, the Dutch scale up that helps...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11
Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01